Words of wisdom. Re: Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised,   double-blind phase III trial.  Escudier B, Pluzanska A, Koralewski P, et al., for the AVOREN Trial investigators.
Shariat
Shahrokh F
SF
University of Texas Southwestern, Dallas, TX, USA. Shahrokh.Shariat@UTSouthwestern.edu
Bolenz
Christian
C
Karakiewicz
Pierre I
PI